TIMP-1 has been observed to prevent TIMP-3 induced apoptosis of keratocytes [33], therefore the lack of the alteration of TIMP-1 concentration after CXL may be beneficial to KC patients. The gene discussed is TIMP1; the disease is keratoconus.